New study explores urinary management in people with spinal cord injury
Rethink Medical has contributed to a new study published in Revista ENFURO exploring urinary management and unmet needs among people with spinal cord injury.
Read moreAll news
Rethink Medical at the Healthcare Investment Forum in Barcelona
Szilvia Endrényi, co-founder and CEO of Rethink Medical, introduces our device T-Control® at the Healthcare Investment Forum of the Barcelona Medical College. The Healthcare Investment Forum in Barcelona has become a benchmark in the Catalan biomedical ecosystem, fostering innovation and entrepreneurship among the community, aiming to connect healthcare entrepreneurs with investors in the sector.
More news
Rethink Medical presents T-Control® at the 48th Spanish Neuroscience Nursing Congress
Rethink Medical participated in the 48th Congress of the Spanish Neuroscience Nursing Association, sharing the journey from identifying an unmet need in clinical practice to developing a regulated medical device.
Read more
Rethink Medical reaches the minimum target of its 2026 investment round
Rethink Medical reached the minimum target of its 2026 investment round ahead of the initially planned closing date.
Read more